Dallas, TX – December 8, 2016 - Puration Inc, (PURA ) is pleased to announce that its EVERx brand’s logo and label design are now complete and plans are underway for its first U.S. production run of the EVERx CBD infused bottled water anticipated to generate $1 million in sales in 2017. After releasing a preliminary design on October 27, the logo included here today is the final, production ready product.
Working with Alkame Holdings’ (OTC: ALKM) wholly owned subsidiary Xtreme Technologies, Puration is now ready for its first U.S. production run of the EVERx Beverage Sports Drink. The initial run will be for the original flavor enhanced with 10 mg of CBD and available in a 16.9 oz bottle. The introduction of two additional flavors can be expected shortly thereafter. EVERx will not only be enhanced with CBD but will utilize Alkame’s patented water technology, which micro-clusters that oxygenate the water, allowing for the CBD to permeate the body’s cells more efficiently.
After several months of working with the Alkame team, Alkame was able to perfect Puration's yet to be announced future flavors. The Company plans on manufacturing the first line within the first quarter of 2017 to begin distribution immediately thereafter.
Brain Shibley, Puration, Inc. CEO states, "Working with Alkame was the right choice. Not only did they get the formulation and lab work done in record time, but all the graphic and design work was completed ahead of schedule.”
Cannabinoil (CBD) for Fitness and Wellness
CBD is an ideal component of a pre and post workout regime. CBD works as an anti-inflammatory and relieves muscle spasms. CBD also works to relieve pain. CBD protects the heart, lungs and brain. Often essential when it comes to high intensity and competitive training, CBD reduces nausea, increases appetite and aides sleep. Ongoing research continues in regard to CBD as a treatment for sports related head trauma. CBD is not just a good addition to an athletes training regime; It can be the foundation of a healthy wellness routine for everyone (CBD Athletic Recovery).
CBD Water and the North American Cannabis Holdings EVERx Brand
Puration has partnered with North American Cannabis Holdings, Inc. (USMJ) to produce a beverage under the North American Cannabis Holdings EVERx Sports and Fitness Nutritional Supplement Brand Name. EVERx CBD infused water will be marketed and sold by Puration in a campaign designed to complement the comprehensive EVERx brand. Puration is targeting an initial $1 million in 2017 sales of EVERx CBD infused water into the health conscious bottled water consumer market. The bottled water market was valued at US $157.27 billion in 2013 and is expected to reach US $279.65 billion by 2020 (Transparency Market Research). Given the magnitude of the bottled water market, management plans to review first quarter performance and potentially increase the first year target at that time.
To learn more about North American Cannabis Holdings: growusmj.com.
Follow the Company on Twitter: US_HEMP
To learn more about Puration: purationinc.com
Follow Puration on Twitter: Puration710
Visit Puration on Facebook: Facebook.com/puration/
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries market and distribute enhanced waters utilizing an exclusive patented formula and technology to create water with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, as well as many other various water treatment solutions to both new and existing business platforms.
For more information, visit alkameholdingsinc.com.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Brian Shibley, CEO